Investment in Day Three Labs Inc. (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended	9 Months Ended	12 Months Ended
	May 01, 2024	Jan. 23, 2024	Apr. 07, 2023	Jan. 31, 2024	Apr. 30, 2024	Jul. 31, 2025	Jul. 31, 2024	Mar. 31, 2025	Mar. 25, 2025	Dec. 23, 2024
Marketable Securities [Line Items]
Warrant exercisable shares (in Shares)						1,058,902
Shares of common stock (in Shares)									12,998,194	3,968,254
Promissory note						$ 614	$ 614
Cash consideration						200
Accrued consideration						200
Principal and accrued interest amounts						2,000
Fair value of previously held interests						700
Non-interest bearing						2,500
Installment note payable						1,700
Funded in receivables						933
Impairment of goodwill						3,050
Gain of recognized investment						30
Convertible Promissory Note [Member]
Marketable Securities [Line Items]
Non-interest bearing								$ 500
Interest rate								20.00%
Initial Investment in Day Three [Member]
Marketable Securities [Line Items]
Purchase of common stock (in Shares)			4,302
Outstanding shares, percentage			38.00%
Diluted basis, percentage			33.00%
Purchase price			$ 3,000
Warrant exercisable shares (in Shares)			7,529
Expires term			5 years
Equity loss					$ 422
Day Three Note I [Member]
Marketable Securities [Line Items]
Promissory note				$ 250
Day Three Note II [Member]
Marketable Securities [Line Items]
Promissory note				150
Day Three Note III [Member]
Marketable Securities [Line Items]
Promissory note				1,000
Day Three Note IV [Member]
Marketable Securities [Line Items]
Promissory note				589
Day Three Acquisition [Member]
Marketable Securities [Line Items]
Company advanced second promissory note						$ 3,100
Acquisition of Day Three [Member]
Marketable Securities [Line Items]
Purchase of common stock (in Shares)	7,194
Purchase price	$ 1,250
Loss on initial investment in day three upon acquisition				$ 1,600
Weighted average amortization period						14 years 8 months 12 days
Purchase agreement for sale		$ 280
Note payable						$ 800
Purchase price (in Dollars per share)	$ 173.75
Funded in receivables	$ 1,000
Minimum [Member]
Marketable Securities [Line Items]
Promissory notes accrue interest at rates				5.01%
Maximum [Member]
Marketable Securities [Line Items]
Promissory notes accrue interest at rates				5.19%
Common Stock [Member]
Marketable Securities [Line Items]
Shares of common stock (in Shares)				13,771
Equity Method and Joint Ventures [Member]
Marketable Securities [Line Items]
Ownership interest				38.00%
Rafael Holdings Inc [Member]
Marketable Securities [Line Items]
Ownership interest						84.00%